125 related articles for article (PubMed ID: 36651175)
1. Evaluation of Copper Chelation Therapy in a Transgenic Rat Model of Cerebral Amyloid Angiopathy.
Ambi A; Stanisavljevic A; Victor TW; Lowery AW; Davis J; Van Nostrand WE; Miller LM
ACS Chem Neurosci; 2023 Feb; 14(3):378-388. PubMed ID: 36651175
[TBL] [Abstract][Full Text] [Related]
2. Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques.
Zhu X; Victor TW; Ambi A; Sullivan JK; Hatfield J; Xu F; Miller LM; Van Nostrand WE
Metallomics; 2020 Apr; 12(4):539-546. PubMed ID: 32104807
[TBL] [Abstract][Full Text] [Related]
3. Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats.
Zhu X; Xu F; Hoos MD; Lee H; Benveniste H; Nostrand WEV
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906317
[TBL] [Abstract][Full Text] [Related]
4. Impact of Non-pharmacological Chronic Hypertension on a Transgenic Rat Model of Cerebral Amyloid Angiopathy.
Stanisavljevic A; Schrader JM; Zhu X; Mattar JM; Hanks A; Xu F; Majchrzak M; Robinson JK; Van Nostrand WE
Front Neurosci; 2022; 16():811371. PubMed ID: 35368255
[TBL] [Abstract][Full Text] [Related]
5. A Novel Transgenic Rat Model of Robust Cerebral Microvascular Amyloid with Prominent Vasculopathy.
Davis J; Xu F; Hatfield J; Lee H; Hoos MD; Popescu D; Crooks E; Kim R; Smith SO; Robinson JK; Benveniste H; Van Nostrand WE
Am J Pathol; 2018 Dec; 188(12):2877-2889. PubMed ID: 30446159
[TBL] [Abstract][Full Text] [Related]
6. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
[TBL] [Abstract][Full Text] [Related]
7. Distinct brain regional proteome changes in the rTg-DI rat model of cerebral amyloid angiopathy.
Schrader JM; Xu F; Van Nostrand WE
J Neurochem; 2021 Oct; 159(2):273-291. PubMed ID: 34218440
[TBL] [Abstract][Full Text] [Related]
8. Copper stabilizes antiparallel β-sheet fibrils of the amyloid β40 (Aβ40)-Iowa variant.
Crooks EJ; Irizarry BA; Ziliox M; Kawakami T; Victor T; Xu F; Hojo H; Chiu K; Simmerling C; Van Nostrand WE; Smith SO; Miller LM
J Biol Chem; 2020 Jul; 295(27):8914-8927. PubMed ID: 32376688
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of urokinase plasminogen activator in rodent models and patients with cerebral amyloid angiopathy.
Vervuurt M; Zhu X; Schrader J; de Kort AM; Marques TM; Kersten I; Peters van Ton AM; Abdo WF; Schreuder FHBM; Rasing I; Terwindt GM; Wermer MJH; Greenberg SM; Klijn CJM; Kuiperij HB; Van Nostrand WE; Verbeek MM
Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12804. PubMed ID: 35266166
[TBL] [Abstract][Full Text] [Related]
10. Robust neuroinflammation and perivascular pathology in rTg-DI rats, a novel model of microvascular cerebral amyloid angiopathy.
Zhu X; Hatfield J; Sullivan JK; Xu F; Van Nostrand WE
J Neuroinflammation; 2020 Mar; 17(1):78. PubMed ID: 32127016
[TBL] [Abstract][Full Text] [Related]
11. rTg-D: A novel transgenic rat model of cerebral amyloid angiopathy Type-2.
Davis J; Xu F; Zhu X; Van Nostrand WE
Cereb Circ Cogn Behav; 2022; 3():100133. PubMed ID: 36324401
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal markers of cerebral amyloid angiopathy and related inflammation in rTg-DI rats.
Schrader JM; Xu F; Agostinucci KJ; DaSilva NA; Van Nostrand WE
Sci Rep; 2024 Apr; 14(1):8441. PubMed ID: 38600214
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Cognitive Decline in a Novel Rodent Model of Cerebral Amyloid Angiopathy Type-1.
Popescu DL; Van Nostrand WE; Robinson JK
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231123
[TBL] [Abstract][Full Text] [Related]
14. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
15. Diffuse white matter loss in a transgenic rat model of cerebral amyloid angiopathy.
Lee H; Xu F; Liu X; Koundal S; Zhu X; Davis J; Yanez D; Schrader J; Stanisavljevic A; Rothman DL; Wardlaw J; Van Nostrand WE; Benveniste H
J Cereb Blood Flow Metab; 2021 May; 41(5):1103-1118. PubMed ID: 32791876
[TBL] [Abstract][Full Text] [Related]
16. Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity.
Bales KR; O'Neill SM; Pozdnyakov N; Pan F; Caouette D; Pi Y; Wood KM; Volfson D; Cirrito JR; Han BH; Johnson AW; Zipfel GJ; Samad TA
Brain; 2016 Feb; 139(Pt 2):563-77. PubMed ID: 26493635
[TBL] [Abstract][Full Text] [Related]
17. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.
Haglund M; Kalaria R; Slade JY; Englund E
Acta Neuropathol; 2006 May; 111(5):430-5. PubMed ID: 16555084
[TBL] [Abstract][Full Text] [Related]
18. Pin1, endothelial nitric oxide synthase, and amyloid-β form a feedback signaling loop involved in the pathogenesis of Alzheimer's disease, hypertension, and cerebral amyloid angiopathy.
Wang JZ; Zhu WD; Xu ZX; Du WT; Zhang HY; Sun XW; Wang XH
Med Hypotheses; 2014 Feb; 82(2):145-50. PubMed ID: 24332564
[TBL] [Abstract][Full Text] [Related]
19. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
[TBL] [Abstract][Full Text] [Related]
20. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.
Greenberg SM; Bacskai BJ; Hernandez-Guillamon M; Pruzin J; Sperling R; van Veluw SJ
Nat Rev Neurol; 2020 Jan; 16(1):30-42. PubMed ID: 31827267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
